Pirfenidone Tablets

Product Description

Product introduction

Pirfenex 400mg Tablet is a prescription medicine used in the treatment of idiopathic pulmonary fibrosis. It reduces scarring and swelling in the lungs and helps to breathe better.

Pirfenex 400mg Tablet is best taken with food. Take it at the same time every day to get the most benefits. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. You should take this medicine for as long as it is prescribed for you.

The most common side effects of this medicine include insomnia, headache, dizziness, dyspepsia, nausea, diarrhea, and photosensitivity. To overcome dizziness, avoid driving or attention-seeking activity. Some people may experience weight loss and other side effects. Monitor your weight regularly or ask for the doctor's advice in such cases. Your doctor also may perform a liver function test while on treatment with this medicine.

Before taking this medicine, let your doctor know if you have liver or kidney disease. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. It makes your skin sun-sensitive, wear protective clothing or apply sunscreen while in direct contact with the sun. Inform your doctor if you are pregnant or breastfeeding.

Comprehensive Treatment for Pulmonary Fibrosis

Pirfenidone Tablets, as an anti-fibrotic agent, are specifically developed to slow the progression of idiopathic pulmonary fibrosis (IPF). By targeting and reducing fibrosis and inflammation in the lungs, these tablets help enhance respiratory function and promote better quality of life for those affected by IPF. As allopathic medicines, they represent a key advancement in pulmonary care.


Flexible Strengths for Personalized Therapy

Available in 200 mg, 400 mg, and 600 mg strengths, Pirfenidone Tablets allow healthcare providers to tailor the dosage to the specific needs of each patient. This flexibility supports effective individual treatment regimens, ensuring optimal therapeutic results in the management of pulmonary fibrosis.